X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ORGS

Closed

Orgenesis Inc

1.49
+0.01 (+0.68%)
Last Update: 01 Jul 2025 22:38:00
Yesterday: 1.48
Day's Range: 1.42 - 1.49
Send
When Written:
 
1.14
Orgenesis Inc. is a biotechnology company that focuses on developing advanced therapies for the treatment of diabetes. The company's main focus is on the development of cell-based therapies that can be used to treat patients with type 1 diabetes, a chronic autoimmune disease that affects millions of people worldwide. Orgenesis has developed a proprietary technology platform that allows the company to manufacture insulin-producing cells from a patient's own liver cells. This approach is known as autologous cell therapy and has the potential to provide a long-lasting cure for type 1 diabetes. In addition to its work on cell-based therapies for diabetes, Orgenesis is also involved in the development of other advanced therapies for a range of diseases and conditions. The company is headquartered in Germantown, Maryland, and has operations in Israel and Belgium.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X